Literature DB >> 12421463

Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.

A Yango1, P Morrissey, R Gohh, A Wahbeh.   

Abstract

Parvovirus B19 is a nonenveloped single-stranded DNA virus that commonly causes a benign childhood infection typically manifesting as a "slapped-cheek" rash. In immunodeficient hosts, this infection can cause persistent anemia and occasionally pancytopenia. Recently, direct renal involvement has been reported in renal transplant recipients leading to various forms of glomerulopathy and allograft dysfunction. Most cases are primary infections and are donor transmitted through the transplanted organ. Clinical and virological response to intravenous immunoglobulin (Ig) is usually excellent. We describe a case of donor-transmitted parvovirus infection in a 23-year-old male who received his first cadaver renal transplant. The patient had an uncomplicated postoperative course with immediate graft function. Eight weeks after transplantation, he presented with fever, polyarthralgia, pancytopenia, and allograft dysfunction. Serological studies revealed elevated IgM titers against parvovirus B19. A renal biopsy was performed, which showed no evidence of acute rejection but with moderate degree of tubular damage. Parvovirus B19 viral DNA was detected in the renal tissue via polymerase chain reaction (PCR). The patient received a 10-day course of intravenous Ig (400 mg/kg/day) with excellent response. His blood count normalized and the allograft improved to baseline function. The incidence of parvovirus infection in renal transplant patients is probably underestimated, because patients are not routinely screened for it and anemia and/or pancytopenia in these patients are often ascribed to immunosuppressive drugs. Because this infection is treatable, we conclude that parvovirus B19 infection should be actively considered in transplant patients presenting with pancytopenia and allograft dysfunction.

Entities:  

Mesh:

Year:  2002        PMID: 12421463     DOI: 10.1034/j.1399-3062.2002.01007.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  5 in total

Review 1.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

2.  Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders.

Authors:  Stefka Krumova; Ivona Andonova; Radostina Stefanova; Polina Miteva; Galina Nenkova; Judith M Hübschen
Journal:  Pathogens       Date:  2022-04-21

Review 3.  Blood disorders typically associated with renal transplantation.

Authors:  Yu Yang; Bo Yu; Yun Chen
Journal:  Front Cell Dev Biol       Date:  2015-03-19

4.  Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.

Authors:  Bianca E Gama; Vanessa E Emmel; Michelle Oliveira-Silva; Luciana M Gutiyama; Leonardo Arcuri; Marta Colares; Rita de Cássia Tavares; Luis F Bouzas; Eliana Abdelhay; Rocio Hassan
Journal:  Transplant Direct       Date:  2017-10-02

5.  Parvovirus B19-associated graft failure after allogeneic hematopoietic stem cell transplantation.

Authors:  Nabila Rattani; Christina Matheny; Michael J Eckrich; Lisa M Madden; Troy C Quigg
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.